An international, observational study to identify in real life practice prognostic factors for response to Botulinum toxin type A injection in subjects with cervical dystonia
Dr. Vijay Peter Misra
Disclosure : Dr Misra received personal compensation from Ipsen Pharma for consulting services and case report forms. He received a speakers fee from Merz pharmaceuticals for speaking at a symposium.
Dr Zakine and Mr Maisonobe are employees of Ipsen pharma.
To be announced!
This presentation will be available soon!